Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-09

Clinical Trial Update: Comprehensive Assessment of Cancer Theranostic Response [NA]

View source ↗

Summary

This clinical trial update indicates that the study 'Comprehensive Assessment of Cancer Theranostic Response' is currently recruiting for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AIQ Solutions | Conditions: Prostate Cancer | NA | Status: RECRUITING